Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 20 to 80

Comparing Remimazolam and Propofol for sedation during endoscopic procedures

Official title: The Comparison of Remimazolam or Propofol Used Alone Versus in Combination for Moderate Sedation During Endoscopic Examination and Treatment.

Run by Kaohsiung Veterans General Hospital. · NCT06777758 · Data updated 2026-11-12

This study is testing whether using Remimazolam alone, Propofol alone, or a combination of both can provide better and safer sedation for patients undergoing endoscopic procedures.

Quick facts

PhasePhase 4
Study typeInterventional
Ages20 Years to 80 Years
SexAll
Enrollment90 (estimated)
SponsorKaohsiung Veterans General Hospital.
Academic / other
Locations1 site (Kaohsiung City)
StatusRecruiting
StartedFebruary 12, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMay 8, 2025
Trial IDNCT06777758 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 20-80 years undergoing upper gastrointestinal endoscopic examinations or therapies with an ASA classification of I to III.

Probably not a fit

Patients with allergies to Propofol or Remimazolam, those requiring emergency surgery, or individuals with significant liver or kidney impairment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the efficacy and safety of Remimazolam, both alone and in combination with Propofol, for moderate sedation during endoscopic examinations and treatments. It is a prospective, randomized, single-center study where eligible patients will be divided into three groups: one receiving Propofol, another receiving Remimazolam, and the last receiving both medications. The study will monitor various parameters including anesthesia depth, vital signs, recovery times, and patient satisfaction to determine the best sedation approach.

Why it matters

Potential benefit: If successful, this study could improve sedation practices during endoscopic procedures, leading to better patient outcomes and reduced postoperative complications.

How similar studies have gone: Other studies have shown promising results with similar sedation approaches, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects are between 20-80 years old.
* Anesthesiologists rated ASA as between I and III.
* Patients undergoing upper gastrointestinal endoscopic examination or therapy.

Exclusion Criteria:

* Allergy to Propofol, Remimazolam, or opioid medications.
* Emergency surgery.
* Pregnancy.
* History of malignant hyperthermia.
* Impaired liver or kidney function.
* Airway difficulties due to pharyngeal tumors.
* Refusal to participate.

Where it's running

  • Kaohsiung Veterans General Hospital
    Kaohsiung City, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.